All In MedTech

Device Trial Radar · NCT06604884

NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study

Neurovascular Product Surveillance Registry (NV PSR INSPIRE) Pipeline™ Vantage Embolization Device With Shield Technology™ Post Approval Study (PAS)

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

118

Planned (sponsor's estimate)

Start

Dec 12, 2025

Primary completion

Aug 2029

Study completion Sep 2033

Sponsor

Sponsor type
Industry
First posted
Sep 20, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 22 years

Summary

As written by the sponsor on the registry.

The purpose of the Pipeline™ Vantage Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Vantage PAS") is to collect safety and effectiveness data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Vantage Embolization Device with Shield Technology™ ("Pipeline™ Vantage Device") in a post approval setting.

Conditions

  • Intracranial Aneurysm

Interventions

  • Treatment of Intracranial AneurysmsDevice

    Embolization of aneurysms using the Pipeline™ Vantage Embolization Device with Shield Technology™

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of the composite outcome (Occlusion of the target aneurysm, Significant parent artery stenosis, Retreatment of the target aneurysm) at 1 year post-procedure.Time frame: 1 Year

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Baptist Medical Center Jacksonville

    Jacksonville, Florida · Recruiting

  • Wellstar Research Institute

    Marietta, Georgia · Recruiting

  • Endeavor Health

    Evanston, Illinois · Recruiting

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.